Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma
ConclusionPlasma miR-148a is a potential non-invasive biomarker for HCC screening, especially for those with negative or low AFP. Detection of miR-148a might be a complementary approach to AFP for predicting HCC occurrence.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology